Search details
1.
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial.
Nat Med
; 29(11): 2844-2853, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37872225
Results
1 -
1
de 1
1
Next >
>>